Vyvgart hytrulo 1,008MG-11,200 5.6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV4B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,488
Award facts
- Contract value 100% obligated
- $23,488.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,488.32 to AmerisourceBergen Drug Corp for the supply of Vyvgart Hytrulo (1,008 mg–11,200 5.6 mL), a pharmaceutical product used in the treatment of autoimmune myasthenia gravis. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and carries an ultimate completion date of February 19, 2026. The awardee, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract falls under AmerisourceBergen's parent company, Cencora, Inc., which operates an extensive portfolio of federal contracts across multiple therapeutic domains.
This delivery order is executed under Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities. Through this arrangement, the Defense Logistics Agency fulfills critical pharmaceutical requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions, leveraging AmerisourceBergen's established capability to efficiently deliver essential medical commodities on a global scale.
Quick answers
Who was awarded contract SPE2DR26FQV4B?
SPE2DR26FQV4B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV4B worth?
The government has obligated $23,488 on SPE2DR26FQV4B.
Is contract SPE2DR26FQV4B an order under another contract?
Yes. SPE2DR26FQV4B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV4B competed?
The extent of competition for SPE2DR26FQV4B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award